Wolfgang Fischer
Chief Operating Officer bei AFFIMED N.V.
Vermögen: 528 240 $ am 30.04.2024
Aktive Positionen von Wolfgang Fischer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AFFIMED N.V. | Chief Operating Officer | 13.09.2017 | - |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Chief Operating Officer | 01.01.2017 | - |
Karriereverlauf von Wolfgang Fischer
Ehemalige bekannte Positionen von Wolfgang Fischer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Corporate Officer/Principal | 01.01.2003 | - |
Ausbildung von Wolfgang Fischer
Swiss Federal Institute of Technology | Doctorate Degree |
University of Würzburg Medical School | Doctorate Degree |
Statistik
International
Deutschland | 4 |
Schweiz | 3 |
Operativ
Chief Operating Officer | 2 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Consumer Services | 3 |
Commercial Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AFFIMED N.V. | Health Technology |
Private Unternehmen | 2 |
---|---|
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
- Börse
- Insiders
- Wolfgang Fischer
- Erfahrung